GLP-1 Medications and Mental Health: What New 2026 Research Really Says
If you or someone you love lives with depression, bipolar disorder, schizophrenia, or another serious mental health condition, medical appointments can sometimes feel divided into separate conversations: mental health in one room, physical health in another.
But the mind and body are connected. Cardiovascular health, blood sugar, sleep, stress, medications, mood, and daily routines can all influence one another. That is why new research about GLP-1 medications deserves a thoughtful, whole-person discussion.
A study highlighted in a September 30, 2026, Clinical Advisor report found that adults with serious mental illness and type 2 diabetes who began a GLP-1 receptor agonist had lower mortality and cardiovascular risk than similar adults who began an SGLT2 inhibitor.
This is encouraging news. It is also research that needs to be understood carefully, not turned into a promise, a prescription, or a reason to change medication without medical guidance.
Why This Research Matters
People living with serious mental illness often die years earlier than the general population. Much of this gap is connected not only to mental health symptoms, but also to cardiovascular disease, diabetes, metabolic conditions, smoking, chronic stress, limited access to care, and medication-related changes in weight or blood sugar.
Some psychiatric medications are essential and life-changing. At the same time, they may affect appetite, metabolism, or energy for some people. This does not mean that a person should stop or avoid psychiatric treatment. It means the full picture deserves attention from a coordinated care team.
The 2026 study is one of the first large analyses to look specifically at GLP-1 medications in adults with serious mental illness. Researchers examined health records involving more than 195,000 matched pairs of adults with serious mental illness and type 2 diabetes.
They compared people who started a GLP-1 receptor agonist, such as semaglutide or medications in the tirzepatide family, with people who started an SGLT2 inhibitor, another type of diabetes medication.
Over four years:
Death occurred in about 4.91% of GLP-1 users compared with 6.45% of SGLT2 inhibitor users.
GLP-1 use was associated with about a 24% lower relative risk of death.
GLP-1 users also experienced fewer major cardiovascular events.
The benefits appeared within the first year and continued during the study period.
The findings were seen across serious mental illness subgroups, with much of the signal driven by semaglutide and tirzepatide.
These numbers are meaningful, especially for a population already facing elevated cardiovascular and metabolic risk.
What the Study Does, and Does Not, Prove
The study offers an important association. It does not prove that GLP-1 medications directly caused people to live longer.
This was an observational study using electronic health record data rather than a randomized clinical trial. Even with careful matching, researchers cannot completely account for every difference between people who received one medication class and those who received another. Access to care, medication adherence, income, other medical conditions, lifestyle factors, and prescribing decisions may all influence outcomes.
The findings also apply most directly to adults with serious mental illness and type 2 diabetes. They do not establish that GLP-1 medications provide the same mortality benefit for every person with a mental health diagnosis, every person seeking weight loss, or every person without diabetes.
A GLP-1 medication may be appropriate for one person and not appropriate for another. Your medical history, kidney function, cardiovascular risk, other medications, side effects, insurance coverage, and treatment goals all matter.
The Mind-Body Connection Is Part of Mental Health Care
When I work with clients, I do not want to look only at symptoms in isolation. I want to understand the whole person: what their body is experiencing, what pressures they are carrying, what support they have, and what changes feel realistic.
Metabolic health can affect mental well-being in several ways. Blood sugar fluctuations, poor sleep, chronic inflammation, medication side effects, and cardiovascular concerns can contribute to fatigue, irritability, anxiety, low motivation, or difficulty concentrating. At the same time, depression, trauma, stress, and emotional overwhelm can make it harder to attend medical appointments, prepare meals, move regularly, take medication consistently, or ask for help.
This is not about blaming anyone. It is about recognizing that health behaviors are shaped by stress, access, relationships, culture, work demands, and emotional safety.
For a working professional, that may mean exploring how treatment fits around a demanding schedule. For a family, it may mean learning how to offer support without policing food, weight, medication, or mood. For someone living with serious mental illness, it may mean creating a plan that respects autonomy while making medical care easier to manage.
Therapy can support the emotional and behavioral side of this process. I can help clients navigate body image concerns, treatment anxiety, shame, motivation, stress, changes in eating patterns, and communication with loved ones. Therapy does not replace medical care, but it can make it easier to participate in care with clarity and support.
What This Means for You: Practical Next Steps
If you are wondering whether a GLP-1 medication may fit into your care, consider these steps:
1. Ask your prescriber specific questions
Talk with your primary care clinician, endocrinologist, psychiatrist, or another qualified medical prescriber. You might ask:
Is a GLP-1 medication medically appropriate for me?
How would it interact with my current medications?
What benefits and side effects should I watch for?
How might we monitor blood sugar, weight, cardiovascular health, and mood?
What will the cost be, and does my insurance cover it?
What should I do if I miss a dose or experience a concerning symptom?
The 2026 research may be one helpful part of that conversation. It is not a substitute for individualized medical advice.
2. Track mood alongside physical changes
If you begin a new medication, consider keeping a simple record of mood, sleep, appetite, energy, anxiety, and physical symptoms. Notice whether emotional changes occur alongside changes in eating, weight, blood sugar, or medication dosage.
Share meaningful changes with your medical and mental health providers. Tracking is not about judging yourself. It is a way to notice patterns and give your care team better information.
3. Do not stop medication on your own
Do not stop a GLP-1 medication, psychiatric medication, diabetes medication, or any other prescription without speaking with the clinician who prescribed it. Abrupt changes can create physical or emotional risks.
If cost, side effects, stigma, or access is making treatment difficult, tell your providers. Those are care-planning issues, not personal failures.
4. Invite coordinated support
With your permission, your therapist and medical providers may be able to support a more connected plan. You remain at the center of that process. A respectful team should listen to your priorities, explain options clearly, and help you make informed decisions.
How Therapy Can Help Alongside Medical Care
At Talk to Heal Counseling Center, I believe effective therapy should feel safe, supportive, and respectful, not judgmental or disconnected from real life.
We can work together on:
Managing anxiety about health or medication changes
Processing fear, grief, frustration, or stigma
Building routines that support sleep, nutrition, movement, and appointments
Discussing body image and self-esteem with compassion
Strengthening communication between clients, family members, and providers
Supporting medication routines without shame or pressure
Identifying strengths, resilience, and realistic next steps
I do not prescribe GLP-1 medications or make decisions for your medical team. Instead, I partner with your existing care network by supporting the emotional, relational, and behavioral parts of your health journey.
Our clinicians provide psychotherapy in many different languages, helping clients and families feel more understood and at home in care. We work with many insurance providers, including UHC, Aetna, and Cigna, along with others. Insurance coverage can vary, so our team can help you ask billing questions.
A Hopeful Direction for Whole-Person Care
This new research does not give us a simple answer for everyone. It does give clinicians, families, and people living with serious mental illness a stronger reason to take cardiovascular and metabolic health seriously.
Your mental health and physical health are not competing priorities. Both deserve attention. With medical guidance, therapy, practical support, and a care plan built around your goals, it is possible to move forward with greater understanding and confidence.
If you are in Georgia and would like support, book a free 15-minute consultation or use our online booking page.
Book Now or get in touch at 404-369-3838. Care is provided only in the State of Georgia.
This article is for educational purposes and is not medical advice. Talk with your qualified medical prescriber before starting, stopping, or changing any medication.
Sources and Further Reading
Comments